National and Kapodistrian University of Athens
Προγνωστικοί παράγοντες σε προχωρημένο καρκίνο του στομάχου
Abstract
dc:descriptionBackground: Most patients with gastric cancer present with locally advanced or metastatic disease on diagnosis, despite the availability of advanced imaging techniques. For patients with unresectable disease at time of diagnosis and for those whose disease recurs after primary therapy, gastric cancer is incurable and therapy is palliative. The aim of this study was to investigate possible prognostic factors of survival in such patients. Methods: 311 such patients were studied retrospectively. 19 potential prognostic variables such as demographics, clinical parameters, biochemical markers and treatment modality were examined. Results: On multivariate analysis favorable factors of response to chemotherapy were: younger age, lymph node metastases, absence of liver metastases, good performance status, normal CA19.9, LDH and albumin values. Unfavorable factors that influenced survival increasing the risk of death were: liver metastases, local recurrence, abdominal and peritoneal metastases, poor performance status, increased CA19.9 and LDH values, blood transfusion and weight loss >10%. Factors that unfavorably influenced both response to chemotherapy (by decreasing its efficiency) and survival (by increasing the risk of death) were: presence of liver metastases, poor performance status, increased LDH and CA19.9 values. Conclusion: We defined factors that are related to the outcome in patients with metastatic, unresectable gastric cancer undergoing chemotherapy. We conclude that in the above setting the main factors that may improve survival and response to therapy are normal LDH and CA19.9 values, absence of liver metastases and good performance status.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Φαρμακίδης, Αλέξανδρος
Subjects
dc:subject × 20- Καρκίνος στομάχου, Προχωρημένος
- Καρκίνος στομάχου, Ανεγχείρητος
- Επιβίωση, Προγνωστικοί παράγοντες
- Θεραπεία, Προγνωστικοί παράγοντες ανταπόκρισης στη
- Κατάσταση σωματικής ικανότητας
- Επίπεδα δείκτη CA. 19.9
- Υψηλά επίπεδα LDH
- Ηπατικές μεταστάσεις
- Gastric cancer, Advanced
- Gastric cancer, Unresectable
- Survival,Prognostic factors
- Prognostic factor of response in the theraphy
- Performance status
- Values CA 19.9
- Increased values LDH
- Liver metastases
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24417